Skip to main content
Top
Published in: International Cancer Conference Journal 2/2022

01-04-2022 | Computed Tomography | Case report

Cushing syndrome secondary to a mediastinal carcinoid tumor: a case report

Authors: Reza Ershadi, Matin Vahedi, Behnaz Jahanbin, Javad Sarbazzadeh, Shahab Rafieian

Published in: International Cancer Conference Journal | Issue 2/2022

Login to get access

Abstract

Neuroendocrine tumors (NET) are a rare and diverse set of malignancies that can develop anywhere within the body. ACTH-producing mediastinal NETs often originate from the thymus in the anterior mediastinum and are very rare. Primary diagnostic modalities for NETs include CT scan, MRI, scintigraphy, and Ga-DOTA PET scan. Here we report a case of a young male without any past medical history presenting with hypercortisolism secondary to a middle mediastinal typical carcinoid tumor. The patient underwent a successful resection which reduced serum ACTH levels. To the best of our knowledge, this is the first case of Cushing syndrome caused by a middle mediastinal NET.
Literature
1.
go back to reference Valassi E et al (2011) The European Registry on Cushing’s syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol 165(3):383–392CrossRef Valassi E et al (2011) The European Registry on Cushing’s syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol 165(3):383–392CrossRef
2.
go back to reference Miller BS, Auchus RJ (2020) Evaluation and treatment of patients with hypercortisolism: a review. JAMA Surg 155(12):1152–1159CrossRef Miller BS, Auchus RJ (2020) Evaluation and treatment of patients with hypercortisolism: a review. JAMA Surg 155(12):1152–1159CrossRef
3.
go back to reference Oronsky B et al (2017) Nothing but NET: a review of neuroendocrine tumors and carcinomas. Neoplasia 19(12):991–1002CrossRef Oronsky B et al (2017) Nothing but NET: a review of neuroendocrine tumors and carcinomas. Neoplasia 19(12):991–1002CrossRef
4.
go back to reference Young K et al (2015) Pancreatic neuroendocrine tumors: a review. Future Oncol 11(5):853–864CrossRef Young K et al (2015) Pancreatic neuroendocrine tumors: a review. Future Oncol 11(5):853–864CrossRef
5.
go back to reference Nieman LK et al (2008) The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93(5):1526–1540CrossRef Nieman LK et al (2008) The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93(5):1526–1540CrossRef
6.
go back to reference Nieman LK et al (2015) Treatment of Cushing’s Syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 100(8):2807–2831CrossRef Nieman LK et al (2015) Treatment of Cushing’s Syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 100(8):2807–2831CrossRef
7.
go back to reference Li D et al (2019) Cardiovascular risk and mortality in patients with active and treated hypercortisolism. Gland Surg 9(1):43–58CrossRef Li D et al (2019) Cardiovascular risk and mortality in patients with active and treated hypercortisolism. Gland Surg 9(1):43–58CrossRef
8.
go back to reference Guo W et al (2018) Effect of hypercortisolism on bone mineral density and bone metabolism: A potential protective effect of adrenocorticotropic hormone in patients with Cushing’s disease. J Int Med Res 46(1):492–503CrossRef Guo W et al (2018) Effect of hypercortisolism on bone mineral density and bone metabolism: A potential protective effect of adrenocorticotropic hormone in patients with Cushing’s disease. J Int Med Res 46(1):492–503CrossRef
9.
go back to reference Melosky B (2018) Advanced typical and atypical carcinoid tumours of the lung: management recommendations. Curr Oncol 25(Suppl 1):S86-s93CrossRef Melosky B (2018) Advanced typical and atypical carcinoid tumours of the lung: management recommendations. Curr Oncol 25(Suppl 1):S86-s93CrossRef
10.
go back to reference Zhu S et al (2016) Invasive atypical thymic carcinoid: three case reports and literature review. Onco Targets Ther 9:6171–6176CrossRef Zhu S et al (2016) Invasive atypical thymic carcinoid: three case reports and literature review. Onco Targets Ther 9:6171–6176CrossRef
Metadata
Title
Cushing syndrome secondary to a mediastinal carcinoid tumor: a case report
Authors
Reza Ershadi
Matin Vahedi
Behnaz Jahanbin
Javad Sarbazzadeh
Shahab Rafieian
Publication date
01-04-2022
Publisher
Springer Singapore
Published in
International Cancer Conference Journal / Issue 2/2022
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-022-00542-1

Other articles of this Issue 2/2022

International Cancer Conference Journal 2/2022 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine